Uni-Bio Science Unit to Renew Lease for China Premises

MT NewswiresDec 24 19:42

Express News | State Council meeting: Deploy measures to deepen the reform of Pharmaceutical and medical instruments regulatory system to promote high-quality development of the pharmaceutical industry.

BreakingsDec 24 19:10

The current cycle of Traditional Chinese Medicine materials is entering a downturn phase, and pharmaceutical companies may face a cost "turning point."

In the second half of 2024, the prices of Traditional Chinese Medicine materials are expected to decline overall; the semi-annual and third quarter reports of this year show that the gross margin of some Chinese Patent Medicine listed companies has significantly decreased, indicating a notable impact of the fluctuation in Traditional Chinese Medicine material prices on costs. However, with the retreat in Traditional Chinese Medicine material prices, production costs for companies will also decrease.

cls.cnDec 19 22:27

Uni-Bio Science Group Appoints COO; Shares Slide 3%

MT NewswiresDec 17 13:25

UNI-BIO GROUP (00690.HK) has appointed Wen Yalei as Executive Director and Chief Operating Officer.

Gelonghui, December 17, UNI-BIO GROUP (00690.HK) announced that Wen Yalei has been appointed as Executive Director and Chief Operating Officer, effective from December 17, 2024.

Gelonghui FinanceDec 17 12:08

Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.

The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.

Zhitong FinanceDec 16 14:21